4-amino-3-(5-chloro-2-thienyl)butyric acid has been researched along with Arbaclofen in 1 studies
| Studies (4-amino-3-(5-chloro-2-thienyl)butyric acid) | Trials (4-amino-3-(5-chloro-2-thienyl)butyric acid) | Recent Studies (post-2010) (4-amino-3-(5-chloro-2-thienyl)butyric acid) | Studies (Arbaclofen) | Trials (Arbaclofen) | Recent Studies (post-2010) (Arbaclofen) |
|---|---|---|---|---|---|
| 6 | 0 | 5 | 11 | 0 | 6 |
| Protein | Taxonomy | 4-amino-3-(5-chloro-2-thienyl)butyric acid (IC50) | Arbaclofen (IC50) |
|---|---|---|---|
| Gamma-aminobutyric acid type B receptor subunit 2 | Rattus norvegicus (Norway rat) | 0.086 | |
| Gamma-aminobutyric acid type B receptor subunit 1 | Rattus norvegicus (Norway rat) | 0.086 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, KM; Colby, DA; Doerksen, RJ; Hockerman, GH; Roy, KK | 1 |
1 review(s) available for 4-amino-3-(5-chloro-2-thienyl)butyric acid and Arbaclofen
| Article | Year |
|---|---|
Activation of the γ-Aminobutyric Acid Type B (GABA(B)) Receptor by Agonists and Positive Allosteric Modulators.
Topics: Animals; GABA Agonists; GABA Antagonists; GABA Modulators; Humans; Molecular Conformation; Receptors, GABA-B; Structure-Activity Relationship | 2015 |